Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.
|Slideshows|March 21, 2017
ACC 2017: CV Risk Factors
Author(s)Samantha J. Peterson
Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.
Advertisement
Presentations at the American College of Cardiology’s Annual Scientific Sessions included potential heart issues related to Zika infection, risk of stroke and heart failure with cannabis use, and neurocognitive impairment with PCSK9 variants.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
ELEVIDYS Shows Sustained Functional Differences vs External Controls in Older Ambulatory Duchenne Patients
2
Dompé Begins Phase 2 Trial Testing Intranasal Nerve Growth Factor for Cerebral Palsy
3
The Road Ahead for Precision Medicine in Multiple Sclerosis
4
NeuroVoices: Ali Habib, MD, on Cemdisiran and the Phase 3 NIMBLE Trial Data in Myasthenia Gravis
5